Does eGFR overexpression relate to triple negative profile and poor prognosis in breast cancer patients in Tunisia?
EGFR overexpression was observed in 28.6% of Tunisian breast carcinoma, associated with unfavorable prognosis and with triple negative tumors. Systemically evaluation of EGFR in breast carcinoma could benefit especially to TN subgroup from EGFR targeting agents.
Awaji criteria improve the sensitivity of ALS diagnosis in patients with bulbar onset, but not in those with limb onset.